Showing results (51-60 of 216) with videos related to

Sort By:
Pageof 22
Journal of Cancer Research and Clinical Oncology|July 28, 2022
Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patientsRyoko Inaba Higashiyama, Hidehito Horinouchi, Aya Kuchiba, et al.
Anticancer Research|January 30, 2026
Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance StatusYoh Yamaguchi, Tatsuya Yoshida, Ryoko Inaba Higashiyama, et al.
Clinical Lung Cancer|November 2, 2025
Genomic Profiles as Predictors of Occult Lymph Node Metastasis and Clinical Outcomes in Early-Stage Clinical N0 Non-Small Cell Lung CancerChihiro Takemura, Tatsuya Yoshida, Yukihiro Yoshida, et al.
Lung Cancer (Amsterdam, Netherlands)|May 19, 2020
Salvage surgery after chemotherapy and/or radiotherapy including SBRT and proton therapy: A consecutive analysis of 38 patientsAki K Kobayashi, Hidehito Horinouchi, Yuko Nakayama, et al.
Thoracic Cancer|February 9, 2019
Mixed response to osimertinib and the beneficial effects of additional local therapyYuki Shinno, Yasushi Goto, Jun Sato, et al.
Thoracic Cancer|February 15, 2019
Malignant pleural effusion as a predictor of the efficacy of anti-PD-1 antibody in patients with non-small cell lung cancerRyota Shibaki, Shuji Murakami, Yuki Shinno, et al.
Thoracic Cancer|June 5, 2025
Successful Treatment of HER2 V659E Mutation-Positive Lung Adenocarcinoma With Trastuzumab Deruxtecan: A Case ReportMariko Nishihara, Yuki Shinno, Yoshihiro Masui, et al.
JTO Clinical and Research Reports|November 24, 2025
Genetic Characteristics of Disease Flare After Lenvatinib Discontinuation in Patients With Thymic Carcinoma: A Brief ReportTomoaki Nakamura, Tatsuya Yoshida, Ken Masuda, et al.
Clinical Lung Cancer|January 10, 2017
Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non-Small-Cell Lung Cancer: A Retrospective AnalysisTetsuhiko Asao, Yutaka Fujiwara, Kota Itahashi, et al.
Clinical Lung Cancer|May 26, 2022
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic TumorYuki Shinno, Akihiko Yoshida, Ken Masuda, et al.
Pageof 22